A Study of Different Formulations of the L-PPDS in Subjects With OH or OAG

Completed · Phase 2

Conditions studied: Glaucoma, Ocular Hypertension

In brief

The purpose of this study is to evaluate the safety and preliminary efficacy of two formulations of the Latanoprost-PPDS in subjects with ocular hypertension or open-angle glaucoma.

Key facts

Study ID

NCT00967811

Run by

Mati Therapeutics Inc.

People needed

83

Starts

2009-08-01

Expected to finish

2010-05-01

Last updated by the study team

2013-09-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects over 18 years of age diagnosed with ocular hypertension or open-angle glaucoma
• Subjects who have a best corrected visual acuity of 20/100 or better

You may not qualify if…

• Subjects who wear contact lenses
• Subjects who have uncontrolled medical conditions
• Subjects requiring chronic topical artificial tears, lubricants, and/or requiring any other chronic ocular topical medications
• Subjects who have a history of chronic or recurrent inflammatory eye disease

Where it is running

• Study site — Menlo Park, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.